PIK3CA Oncogenic Mutations in Breast and Colon Cancers: Development of Targeted Anticancer Drugs and Diagnostics

Project title: PIK3CA Oncogenic Mutations in Breast and Colon Cancers: Development of Targeted Anticancer Drugs and Diagnostics
Coordinator: Dr. Argiris Efstratiadis; BRF Academy of Athens
Funding: OPERATIONAL PROGRAMMES 'COMPETITIVENESS & ENTREPRENEURSHIP' National Strategic Reference Framework NSRF 2007-1013 National Action: 'COOPERATION', Sub-action II: 'Large Scale Cooperative Projects
Total Budget: 2.453.625 €

Tags: drug discovery

Address:	20, Delfon Street
	151 25 Marousi,
	Athens-Greece

Phone:	+30-210-6622386
Fax:	+30-210-6622332
Email:	This email address is being protected from spambots. You need JavaScript enabled to view it.

PIK3CA Oncogenic Mutations in Breast and Colon Cancers: Development of Targeted Anticancer Drugs and Diagnostics

Contact us